Skip to content

JDRF Announces Joint Diabetes Research Program with The Israel Science Foundation

October 27, 2010

JDRF Announces Joint Diabetes Research Program with The Israel Science Foundation: NEW YORK, Oct. 21, 2010 – JDRF announced today that it has established a research partnership with JDRF Israel and the Israel Science Foundation (ISF), a prominent research organization in Israel, to encourage innovative research focused on accelerating progress toward a cure for type 1 diabetes. JDRF and ISF are committing up to $3 million USD each over a three-year period to support type 1 diabetes research in Israel.

The program will focus on developing a better understanding of the autoimmune response that causes human type 1 diabetes and discovering novel therapeutic approaches to eliminate or prevent the autoimmune response.

It will also focus on beta cell therapies or therapies that restore the ability to produce insulin by either replacing or regenerating insulin producing cells. Research funded will address the challenges of developing replenishable sources of islet cells for transplantation and discovering new targets and pathways to regenerate endogenous beta cells in the body.

“This partnership is an exciting opportunity to support innovative research to overcome some of the main hurdles we face in type 1 diabetes research today,” said Dr. Richard Insel, Chief Scientific Officer for JDRF. “JDRF has been a long-time supporter of type 1 diabetes research in Israel. With this program, we look to extend and build on these efforts and recruit more scientific talent from Israel to the field and help accelerate progress toward our goal of a cure for type 1 diabetes and its complications.”

“Strengthening biomedical and clinical research in Israel has become a high priority issue for ISF over the past several years,” said Professor Benny Geiger, Chair of Israel Science Foundation’s academic board. “We are delighted to see our partnership with JDRF become a reality, and would like to thank our colleagues at JDRF International and JDRF Israel for their continued support. This joint program with JDRF, which builds on a recent biomedical initiative with the Legacy Heritage Fund, acknowledges the outstanding research capabilities of Israeli scientists in the field of type 1 diabetes and is an important step toward bringing us closer to a cure for the disease.”

“JDRF Israel is proud to have initiated and managed this partnership with ISF, which will continue to put Israeli scientists at the forefront of diabetes research and to make contributions that will help bring about an end to type 1 diabetes,” said Ishay Eilat, Chairperson of JDRF Israel.

Commitments for new research projects will be awarded in each of the next three years with the first round of pre-proposals due by November 1, 2010 and the full applications due on February 1, 2011. For additional details regarding eligibility and procedures, visit the ISF website, the JDRF website, or the JDRF Israel site.

Article from the Juvenile Diabetes Research Foundation national website.

.

Visit our JDRF Dallas website!

Advertisements
No comments yet

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: